share_log

凯赛生物(688065.SH)：股东天津四通及一致行动人拟大宗交易合计减持不超2%股份

Kaisai Biotech (688065.SH): Shareholder Tianjin Sitong and concerted actors plan to reduce their holdings by no more than 2% in total in bulk transactions

Gelonghui Finance ·  Apr 3 05:13

Gelonghui, April 3, 丨 Kaisai Biotech (688065.SH) announced that according to its own financial requirements, the company's shareholder Tianjin Sitong and Seasource, the co-actor, plan to reduce their holdings of the company's shares through bulk transactions 3 trading days after the disclosure of this reduction announcement, that is, 3 months from April 11, 2024, to no more than 2% of the company's total shares (that is, 11,667,560 shares), of which: Tianjin Sitong Bulk Trading will reduce its holdings by no more than 11,167,560 shares, and the reduction ratio will not exceed 1.914% of the total number of shares of the company; Seasource's bulk transaction reduced its holdings by no more than 500,000 shares, and the reduction ratio did not exceed 0.086% of the company's total shares.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment